Cytokinetics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:KK3A Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Nov 24	Sell€57,432	Fady Malik	Individual	1,042	€55.12
30 Oct 24	Sell€95,634	Fady Malik	Individual	2,000	€47.82
15 Oct 24	Sell€99,403	Fady Malik	Individual	2,000	€49.70
01 Oct 24	Sell€94,152	Fady Malik	Individual	2,000	€47.08
17 Sep 24	Sell€102,111	Fady Malik	Individual	2,000	€51.06
03 Sep 24	Sell€107,636	Fady Malik	Individual	2,084	€51.65
20 Aug 24	Sell€101,293	Fady Malik	Individual	2,000	€50.65
06 Aug 24	Sell€98,239	Fady Malik	Individual	2,000	€49.12
23 Jul 24	Sell€105,054	Fady Malik	Individual	2,000	€52.53
10 Jul 24	Sell€287,528	Robert Blum	Individual	5,733	€50.15
09 Jul 24	Sell€103,408	Fady Malik	Individual	2,000	€51.70
05 Jul 24	Sell€12,762	Robert Harrington	Individual	253	€50.44
01 Jul 24	Sell€579,681	Robert Blum	Individual	11,500	€50.41
25 Jun 24	Sell€100,419	Fady Malik	Individual	2,000	€50.21
17 Jun 24	Sell€1,103,630	Robert Blum	Individual	22,500	€49.05
11 Jun 24	Sell€116,975	Fady Malik	Individual	2,366	€49.44
10 Jun 24	Sell€96,934	Muna Bhanji	Individual	2,000	€48.47
03 Jun 24	Sell€584,209	Robert Wong	Individual	13,011	€44.90
03 Jun 24	Sell€70,596	Robert Harrington	Individual	1,580	€44.68
09 Apr 24	Sell€273,854	Fady Malik	Individual	4,000	€68.46

Insider Trading Volume

Insider Buying: KK3A insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of KK3A?
Owner Type	Number of Shares	Ownership Percentage
State or Government	46,132	0.0332%
Private Companies	105,884	0.0763%
Individual Insiders	560,765	0.404%
Institutions	138,031,709	99.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.4%.

Top Shareholders

Top 25 shareholders own 85.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.9%	BlackRock, Inc.	15,252,839	€719.2m	3.95%	0.01%
10.9%	T. Rowe Price Group, Inc.	12,854,932	€606.1m	22.5%	0.05%
10.3%	FMR LLC	12,093,859	€570.2m	4.95%	0.03%
9.97%	The Vanguard Group, Inc.	11,761,605	€554.6m	2.83%	0.01%
6.59%	Wellington Management Group LLP	7,774,970	€366.6m	3.53%	0.06%
5.47%	State Street Global Advisors, Inc.	6,458,324	€304.5m	-1.38%	0.01%
3.97%	Bank of America Corporation, Asset Management Arm	4,687,476	€221.0m	10.5%	0.06%
2.41%	Geode Capital Management, LLC	2,848,584	€134.3m	4.01%	0.01%
2.31%	RTW Investments, LP	2,721,158	€128.3m	0%	1.79%
1.98%	Polar Capital Holdings Plc	2,337,847	€110.2m	-4.76%	0.42%
1.78%	Tavistock Life Sciences	2,100,000	€99.0m	0%	6.52%
1.77%	Pictet Asset Management Limited	2,088,567	€98.5m	18.1%	0.09%
1.61%	Armistice Capital LLC	1,896,575	€89.4m	-8.2%	2.3%
1.59%	Marshall Wace LLP	1,873,701	€88.3m	11.7%	0.13%
1.49%	PFM Health Sciences, LP	1,757,192	€82.9m	0%	5.33%
1.41%	AllianceBernstein L.P.	1,661,014	€78.3m	-11.6%	0.02%
1.27%	Vestal Point Capital, LP	1,500,000	€70.7m	-27.7%	5.83%
1.13%	Northern Trust Global Investments	1,329,654	€62.7m	3.64%	0.01%
1.12%	Charles Schwab Investment Management, Inc.	1,321,391	€62.3m	42.8%	0.01%
1.03%	Westfield Capital Management Company, L.P.	1,212,886	€57.2m	38.9%	0.24%
1.03%	Melqart Asset Management (Uk) Ltd	1,212,258	€57.2m	-27.7%	5.68%
0.99%	Brown Advisory Incorporated	1,165,432	€55.0m	52.9%	0.07%
0.97%	Janus Henderson Group plc	1,143,830	€53.9m	17.2%	0.02%
0.94%	Sarissa Capital Management LP	1,110,000	€52.3m	0%	13.69%
0.93%	Pentwater Capital Management LP	1,100,000	€51.9m	-1.7%	0.98%